Call Options Transactions Made in Q4 2024 in Viridian Therapeutics, Inc.\De (VRDN)
This table provides information about the institutional ownership of Viridian Therapeutics, Inc.\De (VRDN) during Q4 2024. The information is specifically focused on institutions that hold call options of Viridian Therapeutics, Inc.\DE.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2025
Q4 2024
|
J. Goldman & CO LP
New York, NY |
BUY
|
CALL |
20.5KNew |
$366K - $527K
|
20.5K
$318K
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
15K+ 53.19% |
$268K - $386K
|
43.2K
$671K
|
|
Feb 13, 2025
Q4 2024
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
CALL |
7.5KNew |
$134K - $193K
|
7.5K
$116K
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
300+ 0.4% |
$5.36K - $7.71K
|
74.6K
$1.16M
|
|
Feb 14, 2025
Q4 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
CALL |
-7.2K- 12.31% |
$129K - $185K
|
51.3K
$797K
|
|
Feb 14, 2025
Q4 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
CALL |
-24.9K- 12.45% |
$444K - $640K
|
175K
$2.72M
|
|
Feb 14, 2025
Q4 2024
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
CALL |
-87.4K- 45.52% |
$1.56M - $2.25M
|
105K
$1.62M
|